Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>

Vance G. Fowler(Duke University), Sara E. Cosgrove(Johns Hopkins University), Arthur S. Link(Novant Health Forsyth Medical Center), Scott G. Filler(University of California, Los Angeles), Adolf W. Karchmer(Beth Israel Deaconess Medical Center), Henry F. Chambers(San Francisco General Hospital), Graeme N. Forrest(University of Maryland, Baltimore), Marcelo Gareca(Lehigh Valley Hospital-Pocono), Elías Abrutyn(Drexel University), Marcus Zervos(Henry Ford Health System), G. Ralph Corey(Duke Medical Center), Christopher H. Cabell(Pfizer (United States)), Gerd Fätkenheuer(University of Cologne), Ignace Demeyer(Onze Lieve Vrouwziekenhuis Hospital), Connie Price(Denver Health Medical Center), Jack Bernstein(Wright State University), Gloria Vigliani(Cubist Pharmaceuticals (United States)), Susan J. Rehm(Cleveland Clinic), Helen W. Boucher(Tufts Medical Center), Paul Cook(East Carolina University), Alan D. Tice(University of Hawaiʻi at Mānoa), Francis P. Tally(Cubist Pharmaceuticals (United States)), Donald P. Levine(Wayne State University), H.-R. Brodt(Goethe University Frankfurt), Mark E. Rupp(University of Nebraska Medical Center)
New England Journal of Medicine
August 16, 2006
Cited by 1,461


Related Papers